Back
Adaptimmune Therapeutics PLC Stock Price Chart
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Sell
22
ADAP
Adaptimmune Therapeutics PLC
Last Price:
$0.28
Seasonality Move:
-12.29%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.-
The current trend is relatively stagnant and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
Adaptimmune Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.28 | Sell |
| 20-day SMA: | 0.28 | Buy |
| 50-day SMA: | 0.27 | Buy |
| 200-day SMA: | 0.61 | Sell |
| 8-day EMA: | 0.28 | Sell |
| 20-day EMA: | 0.28 | Sell |
| 50-day EMA: | 0.3 | Sell |
| 200-day EMA: | 0.56 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 49.42 | Sell |
| Chaikin Money Flow: | -401711 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.27 - 0.29) | Buy |
| Bollinger Bands (100): | (0.24 - 0.54) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
| May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.28 while ADAP 8-day simple moving average is 0.28, which is a Sell signal.
-
The stock price of ADAP is 0.28 while Adaptimmune Therapeutics PLC 20-day SMA is 0.28, which makes it a Buy.
-
Adaptimmune Therapeutics PLC 50-day simple moving average is 0.27 while ADAP share price is 0.28, making it a Buy technically.
-
ADAP stock price is 0.28 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.61, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
22
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a SellThe current Adaptimmune Therapeutics PLC [ADAP] share price is $0.28. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
74.7M
Price in USD:
0.28
Share Volume:
664.5K
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
1.48
52-Week Low:
0.20
Sell
22
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?The Adaptimmune Therapeutics PLC stock price is 0.28 USD today.
-
Will ADAP stock go up or go down?Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptimmune Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.28 while ADAP 8-day exponential moving average is 0.28, which is a Sell signal.
-
The stock price of ADAP is 0.28 while Adaptimmune Therapeutics PLC 20-day EMA is 0.28, which makes it a Sell.
-
Adaptimmune Therapeutics PLC 50-day exponential moving average is 0.30 while ADAP share price is 0.28, making it a Sell technically.
-
ADAP stock price is 0.28 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.56, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and an increase next year of $0.01 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
-
ADAP Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Adaptimmune Therapeutics PLC is a Sell
-
Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 49.42, which suggest Adaptimmune Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (0.27 - 0.29), which suggest Adaptimmune Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.24 - 0.54), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.